Literature DB >> 12643173

The intriguing diversity of the glucagon gene products.

Pierre J Lefèbvre1.   

Abstract

Mesh:

Substances:

Year:  2002        PMID: 12643173     DOI: 10.1007/s11892-002-0081-7

Source DB:  PubMed          Journal:  Curr Diab Rep        ISSN: 1534-4827            Impact factor:   4.810


× No keyword cloud information.
  7 in total

1.  Miniglucagon (glucagon 19-29): a novel regulator of the pancreatic islet physiology.

Authors:  Stéphane Dalle; Ghislaine Fontés; Anne-Dominique Lajoix; Laurence LeBrigand; René Gross; Gérard Ribes; Michel Dufour; Léo Barry; Dung LeNguyen; Dominique Bataille
Journal:  Diabetes       Date:  2002-02       Impact factor: 9.461

Review 2.  Glucagon-like peptide 2: a nutrient-responsive gut growth factor.

Authors:  D G Burrin; Y Petersen; B Stoll; P Sangild
Journal:  J Nutr       Date:  2001-03       Impact factor: 4.798

Review 3.  Development of glucagon-like peptide-1-based pharmaceuticals as therapeutic agents for the treatment of diabetes.

Authors:  D J Drucker
Journal:  Curr Pharm Des       Date:  2001-09       Impact factor: 3.116

Review 4.  Glucagon and its family revisited.

Authors:  P J Lefèbvre
Journal:  Diabetes Care       Date:  1995-05       Impact factor: 19.112

5.  Glucagon-like Peptide 2.

Authors: 
Journal:  Trends Endocrinol Metab       Date:  1999-05       Impact factor: 12.015

6.  Miniglucagon [glucagon-(19-29)] is a component of the positive inotropic effect of glucagon.

Authors:  C Pavoine; V Brechler; A Kervran; P Blache; D Le-Nguyen; S Laurent; D Bataille; F Pecker
Journal:  Am J Physiol       Date:  1991-05

7.  Structure of the human glucagon gene.

Authors:  J W White; G F Saunders
Journal:  Nucleic Acids Res       Date:  1986-06-25       Impact factor: 16.971

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.